SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-K’ for 12/31/17 – ‘EXCEL’

On:  Thursday, 3/1/18, at 4:09pm ET   ·   For:  12/31/17   ·   Accession #:  944809-18-14   ·   File #:  1-33528

Previous ‘10-K’:  ‘10-K’ on 3/1/17 for 12/31/16   ·   Next:  ‘10-K’ on 3/1/19 for 12/31/18   ·   Latest:  ‘10-K’ on 3/1/24 for 12/31/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/01/18  Opko Health, Inc.                 10-K       12/31/17  111:16M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.56M 
 2: EX-10.26    Material Contract                                   HTML    353K 
 3: EX-10.27    Material Contract                                   HTML     64K 
 4: EX-10.28    Material Contract                                   HTML     55K 
 5: EX-10.29    Material Contract                                   HTML     82K 
 6: EX-21       Subsidiaries List                                   HTML     32K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
18: R1          Document and Entity Information                     HTML     56K 
19: R2          Consolidated Balance Sheets                         HTML    108K 
20: R3          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
21: R4          Consolidated Statements of Operations               HTML     98K 
22: R5          Consolidated Statements of Comprehensive Loss       HTML     53K 
23: R6          Consolidated Statements of Equity                   HTML    130K 
24: R7          Consolidated Statements of Cash Flows               HTML    172K 
25: R8          Consolidated Statements of Cash Flows               HTML     32K 
                (Parenthetical)                                                  
26: R9          Business and Organization                           HTML     36K 
27: R10         Summary of Significant Accounting Policies          HTML    118K 
28: R11         Loss Per Share                                      HTML     36K 
29: R12         Acquisitions, Investments, and Licenses             HTML     74K 
30: R13         Composition of Certain Financial Statement          HTML    302K 
                Captions                                                         
31: R14         Debt                                                HTML    168K 
32: R15         Shareholders' Equity                                HTML     47K 
33: R16         Accumulated Other Comprehensive Income (Loss)       HTML     62K 
34: R17         Equity-Based Compensation                           HTML     80K 
35: R18         Income Taxes                                        HTML    155K 
36: R19         Related Party Transactions                          HTML     43K 
37: R20         Employee Benefit Plans                              HTML     32K 
38: R21         Commitments and Contingencies                       HTML     43K 
39: R22         Strategic Alliances                                 HTML     66K 
40: R23         Leases                                              HTML     52K 
41: R24         Segments                                            HTML    144K 
42: R25         Fair Value Measurements                             HTML    158K 
43: R26         Derivative Contracts                                HTML     58K 
44: R27         Selected Quarterly Financial Data (Unaudited)       HTML     74K 
45: R28         Subsequent Events                                   HTML     35K 
46: R29         Summary of Significant Accounting Policies          HTML    181K 
                (Policies)                                                       
47: R30         Summary of Significant Accounting Policies          HTML     54K 
                (Tables)                                                         
48: R31         Acquisitions, Investments, and Licenses (Tables)    HTML     56K 
49: R32         Composition of Certain Financial Statement          HTML    307K 
                Captions (Tables)                                                
50: R33         Debt (Tables)                                       HTML    148K 
51: R34         Shareholders' Equity (Tables)                       HTML     43K 
52: R35         Accumulated Other Comprehensive Income (Loss)       HTML     60K 
                (Tables)                                                         
53: R36         Equity-Based Compensation (Tables)                  HTML     68K 
54: R37         Income Taxes (Tables)                               HTML    148K 
55: R38         Leases (Tables)                                     HTML     56K 
56: R39         Segments (Tables)                                   HTML    144K 
57: R40         Fair Value Measurements (Tables)                    HTML    159K 
58: R41         Derivative Contracts (Tables)                       HTML     59K 
59: R42         Selected Quarterly Financial Data (Unaudited)       HTML     74K 
                (Tables)                                                         
60: R43         Business and Organization (Details)                 HTML     43K 
61: R44         Summary of Significant Accounting Policies          HTML    162K 
                (Details)                                                        
62: R45         Summary of Significant Accounting Policies -        HTML     53K 
                Schedule of Product Sales Allowances and Accruals                
                (Details)                                                        
63: R46         Loss Per Share - Narrative (Details)                HTML     40K 
64: R47         Acquisitions, Investments, and Licenses -           HTML    181K 
                Narrative (Details)                                              
65: R48         Acquisitions, Investments, and Licenses -           HTML     52K 
                Transition Therapeutics Purchase Price Allocation                
                (Details) (Details)                                              
66: R49         Acquisitions, Investments, and Licenses - Summary   HTML     46K 
                of Investments (Details)                                         
67: R50         Composition of Certain Financial Statement          HTML    171K 
                Captions (Details)                                               
68: R51         Composition of Certain Financial Statement          HTML    290K 
                Captions - Fair Value Assigned to Intangible Asset               
                Classes (Details)                                                
69: R52         Composition of Certain Financial Statement          HTML     36K 
                Captions - Narrative (Details)                                   
70: R53         Composition of Certain Financial Statement          HTML     48K 
                Captions - Changes in Allowance for Doubtful                     
                Accounts, Provision for Inventory Reserve and Tax                
                Valuation (Details)                                              
71: R54         Composition of Certain Financial Statement          HTML     73K 
                Captions - Changes in Goodwill (Detail)                          
72: R55         Debt - Narrative (Details)                          HTML    174K 
73: R56         Debt - Notes (Details)                              HTML     71K 
74: R57         Debt - Inputs Used In Lattice Model (Details)       HTML     46K 
75: R58         Debt - Lines Of Credit (Details)                    HTML     70K 
76: R59         Debt - Mortgage Notes And Other Debt (Details)      HTML     39K 
77: R60         Shareholders' Equity - Narrative (Details)          HTML     59K 
78: R61         Shareholders' Equity (Details)                      HTML     45K 
79: R62         Accumulated Other Comprehensive Income (Loss)       HTML     51K 
                (Details)                                                        
80: R63         Equity-Based Compensation - Narrative (Details)     HTML     80K 
81: R64         Equity-Based Compensation - Option-Pricing Formula  HTML     48K 
                (Details)                                                        
82: R65         Equity-Based Compensation - Summary of Option       HTML     83K 
                Activity (Details)                                               
83: R66         Income Taxes - Benefits (Provision) for Income      HTML     57K 
                Taxes (Details)                                                  
84: R67         Income Taxes - Deferred Income Taxes (Details)      HTML     93K 
85: R68         Income Taxes - Change in Gross Unrecognized Income  HTML     41K 
                (Details)                                                        
86: R69         Income Taxes - Narrative (Details)                  HTML     74K 
87: R70         Income Taxes - Difference in Federal and Effective  HTML     60K 
                Tax Rate (Details)                                               
88: R71         Income Taxes - Reconciliation Losses Before Tax,    HTML     36K 
                US and Foreign Jurisdictions (Details)                           
89: R72         Related Party Transactions - Narrative (Details)    HTML    192K 
90: R73         Employee Benefit Plans (Details)                    HTML     38K 
91: R74         Commitments and Contingencies (Details)             HTML     63K 
92: R75         Strategic Alliances (Details)                       HTML    125K 
93: R76         Leases (Details)                                    HTML     32K 
94: R77         Leases - Schedule of Maturities of Operating        HTML     48K 
                Leases (Details)                                                 
95: R78         Leases - Schedule of Capital Leases (Details)       HTML     35K 
96: R79         Leases - Schedule of Maturities of Capital Leases   HTML     56K 
                (Details)                                                        
97: R80         Segments - Narrative (Details)                      HTML     57K 
98: R81         Segments - Operating Segments (Details)             HTML    102K 
99: R82         Segments - Reconciliation Property Plant and        HTML     36K 
                Equipment, US and Foreign Jurisdictions (Details)                
100: R83         Fair Value Measurements - Summary Of Investments    HTML     40K  
                (Details)                                                        
101: R84         Fair Value Measurements - Assets And Liabilities    HTML     81K  
                Measured At Fair Value (Details)                                 
102: R85         Fair Value Measurements - Notes (Details)           HTML     37K  
103: R86         Fair Value Measurements - Level 3 Reconciliation    HTML     46K  
                (Details)                                                        
104: R87         Fair Value Measurements - Narrative (Details)       HTML     40K  
105: R88         Derivative Contracts - Fair Value and Presentation  HTML     47K  
                (Details)                                                        
106: R89         Derivative Contracts - Losses and Gains on          HTML     40K  
                Derivative Instruments (Details)                                 
107: R90         Selected Quarterly Financial Data (Unaudited)       HTML     51K  
                (Details)                                                        
108: R91         Subsequent Events (Details)                         HTML     47K  
110: XML         IDEA XML File -- Filing Summary                      XML    193K  
109: EXCEL       IDEA Workbook of Financial Reports                  XLSX    157K  
12: EX-101.INS  XBRL Instance -- opk-20171231                        XML   5.01M 
14: EX-101.CAL  XBRL Calculations -- opk-20171231_cal                XML    377K 
15: EX-101.DEF  XBRL Definitions -- opk-20171231_def                 XML   1.42M 
16: EX-101.LAB  XBRL Labels -- opk-20171231_lab                      XML   2.99M 
17: EX-101.PRE  XBRL Presentations -- opk-20171231_pre               XML   1.86M 
13: EX-101.SCH  XBRL Schema -- opk-20171231                          XSD    267K 
111: ZIP         XBRL Zipped Folder -- 0000944809-18-000014-xbrl      Zip    453K  


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/23  Opko Health, Inc.                 10-K       12/31/22  121:20M
 3/01/22  Opko Health, Inc.                 10-K       12/31/21  110:16M
 2/18/21  Opko Health, Inc.                 10-K       12/31/20  111:16M
12/26/18  SEC                               UPLOAD2/21/19    2:39K  Opko Health, Inc.
11/19/18  SEC                               UPLOAD2/21/19    2:54K  Opko Health, Inc.
 9/13/18  SEC                               UPLOAD2/21/19    2:44K  Opko Health, Inc.
 8/03/18  SEC                               UPLOAD2/21/19    2:48K  Opko Health, Inc.
Top
Filing Submission 0000944809-18-000014   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 2:53:53.2pm ET